National Center for Advancing Translational Sciences; Notice of Closed Meetings, 59934 [2012-24013]

Download as PDF 59934 Federal Register / Vol. 77, No. 190 / Monday, October 1, 2012 / Notices limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: September 25, 2012. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2012–24014 Filed 9–28–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Advancing Translational Sciences; Notice of Closed Meetings mstockstill on DSK4VPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; NCATS—SEPA Meeting. Date: October 10–11, 2012. Time: 8:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington DC/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Carol Lambert, Ph.D., Scientific Review Officer, Office of Grants Management and Review, National Center for Advancing Translational Sciences, NIH, 6701 Democracy Blvd., Room 1076, Bethesda, MD 20892, 301–435–0814, lambert@mail.nih.gov. Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; Div. of Comparative Medicine Peer Review Meeting; Office of Research Infrastructure Programs; Div. of Program Coordination, Planning, and Strategic Initiatives; Office of the Director. Date: October 22, 2012. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Sheri A. Hild, Ph.D., Scientific Review Officer, Office of Grants VerDate Mar<15>2010 16:48 Sep 28, 2012 Jkt 226001 Management and Review, National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Blvd., Room 1082, Bethesda, MD 20892–4874, 301– 435–0811, hildsa@mail.nih.gov. Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; LAM Training Programs— Div. of Comp. Med. Peer Review Meeting; Office of Research Infrastructure Programs; Div. of Program Coordination, Planning, and Strategic Initiatives; OD. Date: October 23, 2012. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Sheri A. Hild, Ph.D., Scientific Review Officer, Office of Grants Management and Review, National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Blvd., Room 1082, Bethesda, MD 20892–4874, 301– 435–0811, hildsa@mail.nih.gov. Dated: September 25, 2012. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2012–24013 Filed 9–28–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; Cancer Biology-1. Date: November 7–8, 2012. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Rd., Bethesda, MD 20852. Contact Person: Zhiqiang Zou, MD, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 6116 Executive Blvd., Room 8055A, MSC 8329, Bethesda, MD 20892, 301–402–9415, zouzhiq@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Cancer Biology-2. Date: November 7–8, 2012. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Eun Ah Cho, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Suite 703, Room 7073, Bethesda, MD 20892, 301–435–1822, choe@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Community Clinical Oncology Program Groups (CCOP) (U10). Date: November 7, 2012. Time: 8:30 a.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Ellen K. Schwartz, EDD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8055B, Bethesda, MD 20892–8329, 301–594–1215, schwarel@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; MinorityBased Community Clinical Oncology Program Groups (MB–CCOP) (U10). Date: November 7, 2012. Time: 2:30 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Ellen K. Schwartz, EDD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8055B, Bethesda, MD 20892–8329, 301–594–1215, schwarel@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Exploratory/Developmental Research Programs in Cancer Etiology and Genetics. Date: November 8–9, 2012. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Double Tree by Hilton BethesdaWashington DC, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: David G. Ransom, Ph.D., Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Room 8133, Bethesda, MD 20892–8328, 301–451–4757, david.ransom@nih.gov. Information is also available on the Institute’s/Center’s home page: https:// E:\FR\FM\01OCN1.SGM 01OCN1

Agencies

[Federal Register Volume 77, Number 190 (Monday, October 1, 2012)]
[Notices]
[Page 59934]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-24013]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel; NCATS--SEPA Meeting.
    Date: October 10-11, 2012.
    Time: 8:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington DC/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Carol Lambert, Ph.D., Scientific Review Officer, 
Office of Grants Management and Review, National Center for 
Advancing Translational Sciences, NIH, 6701 Democracy Blvd., Room 
1076, Bethesda, MD 20892, 301-435-0814, lambert@mail.nih.gov.

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel; Div. of Comparative Medicine Peer 
Review Meeting; Office of Research Infrastructure Programs; Div. of 
Program Coordination, Planning, and Strategic Initiatives; Office of 
the Director.
    Date: October 22, 2012.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Rockville, 1750 Rockville Pike, Rockville, MD 
20852.
    Contact Person: Sheri A. Hild, Ph.D., Scientific Review Officer, 
Office of Grants Management and Review, National Center for 
Advancing Translational Sciences, National Institutes of Health, 
6701 Democracy Blvd., Room 1082, Bethesda, MD 20892-4874, 301-435-
0811, hildsa@mail.nih.gov.

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel; LAM Training Programs--Div. of 
Comp. Med. Peer Review Meeting; Office of Research Infrastructure 
Programs; Div. of Program Coordination, Planning, and Strategic 
Initiatives; OD.
    Date: October 23, 2012.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Rockville, 1750 Rockville Pike, Rockville, MD 
20852.
    Contact Person: Sheri A. Hild, Ph.D., Scientific Review Officer, 
Office of Grants Management and Review, National Center for 
Advancing Translational Sciences, National Institutes of Health, 
6701 Democracy Blvd., Room 1082, Bethesda, MD 20892-4874, 301-435-
0811, hildsa@mail.nih.gov.

    Dated: September 25, 2012.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-24013 Filed 9-28-12; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.